Researchers from the University of Chicago recently studied the cost-effectiveness of continuous glucose monitoring for people with type 1 diabetes. The study involved 158 patients with type 1 diabetes. Participants had HbA1C levels greater than 7.5% and a 2:1 ratio to continuous glucose monitoring versus control.
The study showed that the use of continuous glucose monitoring led to an incremental cost-effectiveness ratio of approximately $98,000/quality-adjusted life year. This resulted in reductions in HbA1C, daily use of test strips, and the daily number of hypoglycemia events. From these results, the study authors determined that continuous glucose monitoring not only improves glucose controlling, but it is also cost-effective.
These findings were published in Diabetes Care on April 12, 2018.